Jula Inrig - 04 May 2026 Form 4 Insider Report for Travere Therapeutics, Inc. (TVTX)

Reporting relationship: CHIEF MEDICAL OFFICER
Issuer ticker: TVTX
Reported as of: 04 May 2026
Net transaction value: -$1,015,086
SEC form: 4
Accepted by SEC: 06 May 2026, 20:00:28 UTC
Prior SEC filing: 15 Apr 2026
Next SEC filing: 22 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Elizabeth E. Reed, Attorney-in-Fact

Key filing fact

Jula Inrig filed Form 4 for Travere Therapeutics, Inc. (TVTX) on 06 May 2026.

Key facts

This page summarizes Jula Inrig's Form 4 filing for Travere Therapeutics, Inc. (TVTX).
8 reported transactions and 3 derivative rows are listed below.
Accepted by SEC: 06 May 2026, 20:00.

Change

Previous filing in this sequence was filed on 15 Apr 2026.
Current net transaction value: -$1,015,086.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001902368 Primary reporting owner

Inrig Jula

Relationship: CHIEF MEDICAL OFFICER
Address: C/O TRAVERE THERAPEUTICS, INC., 3611 VALLEY CENTRE DRIVE, SUITE 300, SAN DIEGO
Signature: /s/ Elizabeth E. Reed, Attorney-in-Fact
Signature date: 06 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TVTX transaction

Common Stock

Options Exercise

Transaction value
Shares: +20,000
Change %: +18%
Price: $22.40^*
Shares after: 131,473
Date: 04 May 2026
Ownership: Direct

TVTX transaction

Common Stock

Sale

Transaction value: $900,000
Shares: -20,000
Change %: -15%
Price: $45.00
Shares after: 111,473
Date: 04 May 2026
Ownership: Direct
Footnotes: F1

TVTX transaction

Common Stock

Options Exercise

Transaction value
Shares: +4,250
Change %: +3.8%
Price: $0.000000^*
Shares after: 115,723
Date: 04 May 2026
Ownership: Direct
Footnotes: F2

TVTX transaction

Common Stock

Sale

Transaction value: $101,417
Shares: -2,174
Change %: -1.9%
Price: $46.65
Shares after: 113,549
Date: 05 May 2026
Ownership: Direct
Footnotes: F3

TVTX transaction

Common Stock

Sale

Transaction value: $13,668
Shares: -311
Change %: -0.27%
Price: $43.95
Shares after: 113,238
Date: 06 May 2026
Ownership: Direct
Footnotes: F4

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TVTX transaction Derivative

Employee stock option (right to buy)

Options Exercise

Transaction value
Shares: -20,000
Change %: -37%
Price: $0.000000^*
Shares after: 34,500
Date: 04 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 20,000
Exercise price: $22.40
Footnotes: F5

TVTX transaction Derivative

Performance-based restricted stock units

Award

Transaction value
Shares: +8,500
Change %
Price: $0.000000^*
Shares after: 8,500
Date: 04 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 8,500
Exercise price
Footnotes: F2, F6

TVTX transaction Derivative

Performance-based restricted stock units

Options Exercise

Transaction value
Shares: -4,250
Change %: -50%
Price: $0.000000^*
Shares after: 4,250
Date: 04 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 4,250
Exercise price
Footnotes: F2, F6

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 6 footnotes

Footnote F1

This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.

Footnote F2

On January 31, 2024, the Reporting Person was granted performance restricted stock units (PSUs) covering 8,500 shares of the Issuer's common stock, to vest upon the satisfaction of certain performance criteria. If any such milestone is achieved on a pre-specified accelerated timeline, up to 50% additional shares attributable to such milestone achievement could vest under these PSU grants, with such additional potential shares to vest at a later date in furtherance of retention objectives. On May 4, 2026, 50% of the PSUs vested upon the Issuer's confirmation following the release of its financial results for the quarter ended March 31, 2026 that a performance criterion related to cumulative FILSPARI net revenue had been achieved, and contingent on continuous service by the Reporting Person, on January 31, 2027 an additional 25% of such PSUs will vest due to the timing of the achievement of such cumulative FILSPARI net revenue performance criterion.

Footnote F3

Represents the number of shares required to be sold by the Reporting Person to cover the tax withholding obligation in connection with the settlement of vested performance restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the Reporting Person to fund this tax withholding obligation by completing a "sell to cover" transaction with a brokerage firm designated by the Issuer. This sale does not represent a discretionary trade by the Reporting Person.

Footnote F4

This sale was made pursuant to a written plan adopted on May 28, 2025, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended, and includes the sale of shares to cover the tax obligation that occurred upon the vesting of performance restricted stock units.

Footnote F5

One-fourth of the shares subject to the stock option vested and become exercisable on January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.

Footnote F6

Each PSU represents a contingent right to receive one share of the Issuer's common stock at target, subject to adjustment based on the achievement of applicable performance conditions.